Form 4: Ionis Pharmaceuticals Executive Reports Stock Transaction
Insider Transaction (Form 4)
Patrick R. O'Neil, EVP CLO & General Counsel of Ionis Pharmaceuticals Inc, reported a transaction in 63 shares of common stock on August 31, 2026.
Summary
- Other acquisition/disposition: acquired 63 Common Stock at $51.31 ($3,232) on August 31, 2026; holds 59,205 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Patrick R. O'Neil — Officer (EVP CLO & General Counsel)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Other acquisition/disposition | Common Stock | 63 | $51 | $3.2K | 59,205 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Other acquisition/disposition (63 shares) |
Keywords
insider transaction, Form 4, IONS, IONIS PHARMACEUTICALS INC, neutral, Patrick R. O'Neil
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.